Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies

Clinical Nephrology

Volumn 48, Issue 1, 1997, Pages 41-43

  Kudoh, Y ^a   Kuroda, S ^a   Shimamoto, K ^b   Iimura, O ^b  

^a Kidney Unit   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antineutrophil cytoplasmic autoantibodies; Propylthiouracil; Rapidly progressive glomerulonephritis

Indexed keywords

ANTITHYROID AGENT; IODINE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; PROPYLTHIOURACIL; PROTEINASE;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPERTHYROIDISM; KIDNEY BIOPSY; KIDNEY FUNCTION; LEUKOCYTOCLASTIC VASCULITIS; PURPURA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SEROLOGY; THYROID FUNCTION;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; FEMALE; GLOMERULONEPHRITIS; HUMANS; HYPERTHYROIDISM; MIDDLE AGED; PROPYLTHIOURACIL;

EID: 0030873122     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Amrhein JA, Kenny FM, Ross D 1970 Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. J Pediatr 76: 54-63
2. Carrasco MD, Riera C, Clotet B, Grifol M, Foz M 1987 Cutaneous vasculitis associated with propylthiouracil therapy. Arch Intern Med 147: 1677
3. Cassorla FG, Finegold DN, Parks JS, Tenore A, Thawerani H, Baker L 1983 Vasculitis, pulmonary cavitation, and anemia during antithyroid drug therapy. Am J Dis Child 137: 118-122
4. Cooper DS 1984 Medical progress - antithyroid drugs. N Engl J Med 22: 1353-1362
5. Dolman KM, Gans ROB, Vervaat TJ, Zevenberg G, Maingay D, Nikkels RE, Danker AJM, Von dem Borne AEGK, Goldschmeding R 1993 Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 342: 651-652
6. Geffriaud-Ricouard C, Noel LH, Chauveau D, Houhou S, Grunfeld JP, Lesavre P 1993 Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol 39: 125-136
7. Griswold WR, Mendoza SA, Johnston W, Nichols LS 1978 Vasculitis associsted with propylthiouracil. Wes J Med 128: 543-546
8. Fong PC, Pun KK, Tai YT, Wang C, Yeung RTT 1991 Propylthiouracil hypersensitivity with circumstantial evidence for drug-induced reversible sensorineural deafness: A case report. Horm Res 35: 132-136
9. Houston BD, Crouch ME, Brick JE, Dibanolomeo AG 1979 Apparent vasculitis associated with propylthiouracil use. Arthritis Rheum 22:925-928
10. Kallenberg CGM, Brouwer E, Weening JJ, Tervaert JWC 1994 Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int 46: 1-15
11. McGavack TH, Chevalley J 1954 Untoward hematologic responses to the antithyroid compounds. Am J Med 17: 36-40
12. Stankus CSJ, Johnson NT 1992 Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest 102: 1595-1596
13. Vasily DB, Tyler WB 1980 Propylthiouracil-induced cutaneous vasculitis. Case presentation and review of the literature. JAMA 243: 458-461
14. Vogt BA, Kim Y, Jennette C, Falk RJ, Burke BA, Sinaiko A 1994 Anti-neutrophil cytoplasmic autoantibody-positive crescentic glomer-ulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr 124: 986-988
15. 3H-thymidine incorporation into DNA of peripheral blood lymphocytes after the addition of propylthiouracil. J Clin Endocrinol Metab 43: 1406-1409
16. Wiberg JJ, Nuttall FQ 1972 Methimazol toxicity from high doses. Ann Intern Med 77:414-416
17. Wing SS, Fantus IG 1987 Adverse immunologic effects of antithyroid drugs. CMAJ 136: 121-127
18. Wolf D, Ben-Yehuda A, Okon E, Naparstek Y 1992 Nodular vasculitis associated with propylthiouracil therapy. Cutis 49: 253-255